BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

425 related articles for article (PubMed ID: 20854935)

  • 1. Clinical and laboratory aspects of Ro/SSA-52 autoantibodies.
    Defendenti C; Atzeni F; Spina MF; Grosso S; Cereda A; Guercilena G; Bollani S; Saibeni S; Puttini PS
    Autoimmun Rev; 2011 Jan; 10(3):150-4. PubMed ID: 20854935
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Anti-SSA/Ro and anti-SSB/La antibodies. What's new?].
    Meyer O
    Ann Med Interne (Paris); 2002 Dec; 153(8):520-9. PubMed ID: 12610426
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Anti-52 kDa Ro(SSA) autoantibodies in different autoimmune diseases preferentially recognize epitopes on the central region of the antigen.
    Dorner T; Feist E; Wagenmann A; Kato T; Yamamoto K; Nishioka K; Burmester GR; Hiepe F
    J Rheumatol; 1996 Mar; 23(3):462-8. PubMed ID: 8832984
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antibodies to Ro and La.
    Reichlin M
    Ann Med Interne (Paris); 1998 Feb; 149(1):34-41. PubMed ID: 11490515
    [TBL] [Abstract][Full Text] [Related]  

  • 5. New coupled-particle light-scattering assay for detection of Ro/SSA (52 and 60 kilodaltons) and La/SSB autoantibodies in connective tissue diseases.
    Bizzaro N; Bonelli F; Tonutti E; Tozzoli R; Villalta D
    Clin Diagn Lab Immunol; 2001 Sep; 8(5):922-5. PubMed ID: 11527804
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ro(SSA) and La(SSB) antibodies in the clinical spectrum of Sjögren's syndrome.
    Alexander EL; Hirsch TJ; Arnett FC; Provost TT; Stevens MB
    J Rheumatol; 1982; 9(2):239-46. PubMed ID: 7097683
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The interaction between anti-Ro/SSA and anti-La/SSB autoantibodies and anti-infectious antibodies in a wide spectrum of auto-immune diseases: another angle of the autoimmune mosaic.
    Agmon-Levin N; Dagan A; Peri Y; Anaya JM; Selmi C; Tincani A; Bizzaro N; Stojanovich L; Damoiseaux J; Cohen Tervaert JW; Mosca M; Cervera R; Shoenfeld Y
    Clin Exp Rheumatol; 2017; 35(6):929-935. PubMed ID: 28770708
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Can B cell epitopes of 60 kDa Ro distinguish systemic lupus erythematosus from Sjögren's syndrome?
    Scofield AN; Kurien BT; Gordon TP; Scofield RH
    Lupus; 2001; 10(8):547-53. PubMed ID: 11530996
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Predicting Sjögren's syndrome in patients with recent-onset SLE.
    Hernández-Molina G; Zamora-Legoff T; Romero-Díaz J; Nuñez-Alvarez CA; Cárdenas-Velázquez F; Hernández-Hernández C; Calderillo ML; Marroquín M; Recillas-Gispert C; Ávila-Casado C; Sánchez-Guerrero J
    Rheumatology (Oxford); 2013 Aug; 52(8):1438-42. PubMed ID: 23594470
    [TBL] [Abstract][Full Text] [Related]  

  • 10. High prevalence of autoantibodies against the nuclear high mobility group (HMG) protein SSRP1 in sera from patients with systemic lupus erythematosus, but not other rheumatic diseases.
    Santoro P; De Andrea M; Migliaretti G; Trapani C; Landolfo S; Gariglio M
    J Rheumatol; 2002 Jan; 29(1):90-3. PubMed ID: 11824977
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical significance of anti-Ro/SSA-52 kDa antibodies: a retrospective monocentric study.
    Hervier B; Rimbert M; Colonna F; Hamidou MA; Audrain M
    Rheumatology (Oxford); 2009 Aug; 48(8):964-7. PubMed ID: 19531627
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical and serological heterogeneity in patients with anticentromere antibodies.
    Miyawaki S; Asanuma H; Nishiyama S; Yoshinaga Y
    J Rheumatol; 2005 Aug; 32(8):1488-94. PubMed ID: 16078324
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Detection of anti-ENA autoantibodies in patients with systemic connective tissue diseases. Analytical variability and diagnostic sensitivity of 4 methods].
    Villalta D; Bizzaro N; Tonutti E; Visentin D; Manoni F; Piazza A; Toffolo L; Rizzotti P; Clemen P; Pradella M; Bassetti D; Tozzoli R
    Recenti Prog Med; 1999 Nov; 90(11):579-84. PubMed ID: 10608146
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Specific testing for "isolated" anti-52 kDa SSA/Ro antibodies during standard anti-extractable nuclear antigen testing is of limited clinical value.
    Langguth DM; Morris S; Clifford L; Wilson RJ; Neil J; Hogan PG; Wong RC
    J Clin Pathol; 2007 Jun; 60(6):670-3. PubMed ID: 17557869
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Recombinant 52 kDa Ro(SSA) ELISA detects autoantibodies in Sjögren's syndrome sera that go undetected by conventional serologic assays.
    McCauliffe DP; Wang L; Satoh M; Reeves WH; Small D
    J Rheumatol; 1997 May; 24(5):860-6. PubMed ID: 9150073
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Anti-Ro/SSA and La/SSB antibodies.
    Franceschini F; Cavazzana I
    Autoimmunity; 2005 Feb; 38(1):55-63. PubMed ID: 15804706
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Correlation of anti-60000 SSA antibody and anti-52000 SSA antibody with systemic lupus erythematosus and Sjögren's syndrome].
    Zhang FC; Liu L; Xu D
    Zhonghua Yi Xue Za Zhi; 2007 Jan; 87(1):7-10. PubMed ID: 17403303
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Anti-Ro/SSA and -La/SSB antibodies in patients with connective tissue diseases.
    Yamagata H; Akizuki M; Tojo T; Homma M
    Scand J Rheumatol Suppl; 1986; 61():98-101. PubMed ID: 3495876
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Subclass distribution of maternal and neonatal anti-Ro(SSA) and La(SSB) antibodies in congenital heart block.
    Tseng CE; Caldwell K; Feit S; Chan EK; Buyon JP
    J Rheumatol; 1996 May; 23(5):925-32. PubMed ID: 8724310
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Use of a commercial line blot assay as a screening test for autoantibodies in inflammatory myopathies.
    Rönnelid J; Barbasso Helmers S; Storfors H; Grip K; Rönnblom L; Franck-Larsson K; Nordmark G; Lundberg IE
    Autoimmun Rev; 2009 Sep; 9(1):58-61. PubMed ID: 19285154
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.